Repository logo
 

USP4 Auto-Deubiquitylation Promotes Homologous Recombination.


Change log

Authors

Wijnhoven, Paul 
Konietzny, Rebecca 
Blackford, Andrew N 
Travers, Jonathan 
Kessler, Benedikt M 

Abstract

Repair of DNA double-strand breaks is crucial for maintaining genome integrity and is governed by post-translational modifications such as protein ubiquitylation. Here, we establish that the deubiquitylating enzyme USP4 promotes DNA-end resection and DNA repair by homologous recombination. We also report that USP4 interacts with CtIP and the MRE11-RAD50-NBS1 (MRN) complex and is required for CtIP recruitment to DNA damage sites. Furthermore, we show that USP4 is ubiquitylated on multiple sites including those on cysteine residues and that deubiquitylation of these sites requires USP4 catalytic activity and is required for USP4 to interact with CtIP/MRN and to promote CtIP recruitment and DNA repair. Lastly, we establish that regulation of interactor binding by ubiquitylation occurs more generally among USP-family enzymes. Our findings thus identify USP4 as a novel DNA repair regulator and invoke a model in which ubiquitin adducts regulate USP enzyme interactions and functions.

Description

Keywords

Acid Anhydride Hydrolases, Carrier Proteins, Cell Cycle Proteins, Cell Line, Tumor, DNA Breaks, Double-Stranded, DNA Repair Enzymes, DNA-Binding Proteins, Endodeoxyribonucleases, Humans, MRE11 Homologue Protein, Models, Biological, Nuclear Proteins, Recombinational DNA Repair, Ubiquitin Thiolesterase, Ubiquitin-Specific Proteases, Ubiquitination

Journal Title

Mol Cell

Conference Name

Journal ISSN

1097-2765
1097-4164

Volume Title

60

Publisher

Elsevier BV
Sponsorship
Cancer Research UK (18796)
Wellcome Trust (092096/Z/10/Z)
Cancer Research Uk (None)
Research in the S.P.J. laboratory is funded by CRUK Program Grant C6/A11224, CRUK Project Grant C6/A14831 and the European Community Seventh Framework Program grant agreement no. HEALTH-F2-2010-259893 (DDResponse). R.N. was funded by the Daiichi Sankyo Foundation of Life Sciences fellowship. Cancer Research UK Grant C6946/A14492 and Wellcome Trust Grant WT092096 provided core infrastructure funding. S.P.J receives his salary from the University of Cambridge, supplemented by CRUK. The John Fell Fund 133/075 and the Wellcome Trust grant 097813/Z/11/Z funded research performed by B.M.K and R.K..